The global genomics market is estimated to reach $23bn by 2022. In 2017, the diagnostic test segment held 27% of the global genomics market. The global genomics market is estimated to grow at a CAGR of 11% throughout the forecast period.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 211-page report you will receive 189 charts– all unavailable elsewhere.
The 211-page report provides clear detailed insight into the genomics market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Genomics Market from 2018-2028
• Forecast of the Global Genomics market by Technology:
• Sequencing
• Microarray
• PCR
• Nucleic Acid Extraction and Purification
• Others
• Forecast of the Global Genomics market by Test Type:
• Diagnostic Test
• Genetic Test
• Newborn Screening
• Preimplantation Testing
• Prenatal Testing
• Carrier Testing
• Forecast of the Global Genomics market by Method:
• Molecular Test
• Chromosomal Test
• Biochemical Test
• Forecast of the Global Genomics market by Application:
• Diagnostic
• Drug Discovery
• Precision Medicine
• Others
• Forecast of the Global Genomics market by End-user:
• Research Centers
• Hospitals and Clinics
• Pharmaceutical Companies
• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• North America: US, Canada, Rest of North America
• Europe: Germany, France, UK, Rest of Europe
• Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
• Latin America: Mexico, Brazil, Rest of Latin America
• Middle East & Africa: GCC Countries, South Africa, Rest of Middle East & Africa
Each regional market is further segmented by technology, test-type, method, application and end-user.
• Our study discusses the selected leading companies that are the major players in the genomics market:
• Agilent Technologies, Inc.
• Danaher Corporation
• Eppendorf AG
• BGI Genomics Co. Ltd.
• Eurofins Scientific
• GE Healthcare Life Sciences
• Illumina, Inc.
• Oxford Nanopore Technologies Ltd.
• Qiagen NV
• Roche
• Thermo Fisher Scientific, Inc.
• Research interview with a start-up company in the genomic market.
• This report provides the following qualitative analysis of the genomics market:
• Market Drivers
• Value Chain Analysis of the genomics market
• Porter’s Five Forces Analysis of the genomics market
• Market Attractiveness Analysis in North America, Europe, Asia-Pacific, Latin America, Middle East & Africa of the genomics market by technology, test-type, method, application and end-user.
Visiongain’s study is intended for anyone requiring commercial analyses for the genomics market. You find data, trends and predictions.
Buy our report today Global Genomics Market Report 2018-2028: Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification, Diagnostic Test, Genetic Test, Newborn Screening, Preimplantation Testing, Prenatal Testing, Carrier Testing, Molecular Test, Chromosomal Test, Biochemical Test, Diagnostic, Drug Discovery, Precision Medicine, Research Centers, Hospitals and Clinics, Pharmaceutical Companies and Others.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Research Scope
1.2 Why You Should Read This Report
1.3 Key Questions Answered by This Analytical Report
1.4 Who is This Report For?
1.5 Methodology
1.6 Frequently Asked Questions (FAQ)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2. Introduction to the Genomics Market
2.1 What is Genomics?
2.2 Classification of Genomics Market
2.3 Market Snapshot: Genomics Market (2017 and 2028)
2.4 Genomics Market Forecast 2016-2028
3. Global Genomics Market Dynamics
3.1 Genomics Market: Drivers
3.1.1 Increase in Private and Public Sector Funding
3.2 Value Chain Analysis of the Genomics Market (Genome Sequencing)
3.3 Porter’s Five Forces Analysis of the Genomics Market.
3.4 Threat of New Entrants [Moderate]
3.5 Power of Suppliers [High]
3.6 Power of Buyers [Low]
3.7 Threat of Substitutes [Low]
3.8 Rivalry among Competitors [High]
4. Global Genomics Submarkets
4.1 Global Genomics Market by Technology, 2017
4.2 Global Genomics Market by Test Type, 2017
4.3 Global Genomics Market by Method, 2017
4.4 Global Genomics Market by Application, 2017
4.5 Global Genomics Market by End-user, 2017
4.6 Global Genomics Market by Geography, 2017
5. Global Genomics Market by Technology: Forecast 2018 – 2028
5.1 Global Genomics Market by Technology: 2018 Vs 2028 (Value %)
5.2 Global Genomics Market by Technology: Forecasts 2018 – 2028
6. Global Genomics Market by Test Type: Forecast 2018 - 2028
6.1 Global Genomics Market by Test Type: 2018 Vs 2028 (Value %)
6.2 Global Genomics Market by Test Type: Forecasts 2018 – 2028
7. Global Genomics Market by Method: Forecasts 2018 - 2028
7.1 Global Genomics Market by Method: 2018 Vs 2028 (Value %)
7.2 Global Genomics Market by Method: Forecasts 2018 – 2028
8. Global Genomics Market by Application: Forecasts 2018 - 2028
8.1 Global Genomics Market by Application: 2018 Vs 2028 (Value %)
8.2 Global Genomics Market Forecast by Application, 2018-2028
9. Global Genomics Market by End-User: Forecasts 2018 – 2028
9.1 Global Genomics Market by End-User: 2018 Vs 2028 (Value %)
9.2 Global Genomics Market Forecast by End-User, 2018-2028
10. Global Genomics Market by Region: Forecasts 2018-2028
10.1 Genomics Market Share by Geographic Region, 2018 and 2028 (Value %)
10.2 Global Genomics Market by Region: Forecasts 2018-2028
11. North America Genomics Market Analysis and Forecasts, 2018 - 2028
11.1 North America Genomics Market Outlook
11.2 North America Genomics Market by Technology: Forecasts 2018 – 2028
11.3 North America Genomics Market by Test Type: Forecasts 2018 – 2028
11.4 North America Genomics Market by Method: Forecasts 2018-2028
11.5 North America Genomics Market by Application: Forecasts 2018-2028
11.6 North America Genomics Market by End-user: Forecasts 2018-2028
11.7 North America Genomics Market by Country: Forecasts 2018 - 2028
12. Europe Genomics Market Analysis and Forecasts, 2018 - 2028
12.1 Europe Genomics Market Outlook
12.2 Europe Genomics Market by Technology: Forecasts 2018 – 2028
12.3 Europe Genomics Market by Test Type: Forecasts 2018-2028
12.4 Europe Genomics Market by Method: Forecasts 2018 – 2028
12.5 Europe Genomics Market by Application: Forecasts 2018-2028
12.6 Europe Genomics Market Analysis by End-user: Forecasts 2018-2028
12.7 Europe Genomics Market Analysis by Country: Forecasts 2018-2028
13. Asia-Pacific Genomics Market Analysis and Forecasts, 2018 - 2028
13.1 Asia-Pacific Genomics Market Outlook
13.2 Asia-Pacific Genomics Market by Technology: Forecasts 2018-2028
13.3 Asia-Pacific Genomics Market by Test Type: Forecasts 2018-2028
13.4 Asia-Pacific Genomics Market by Method: Forecasts 2018-2028
13.5 Asia-Pacific Genomics Market by Application: Forecasts 2018-2028
13.6 Asia-Pacific Genomics Market by End-User: Forecasts 2018-2028
13.7 Asia-Pacific Genomics Market Analysis, 2018 - 2028 by Country
14. Middle East & Africa Genomics Market Analysis and Forecasts, 2018 - 2028
14.1 Middle East & Africa Genomics Market Outlook
14.2 Middle East & Africa Genomics Market by Technology: Forecasts 2018 – 2028
14.3 Middle East & Africa Genomics Market by Test Type: Forecasts 2018 – 2028
14.4 Middle East & Africa Genomics Market by Method: Forecasts 2018-2028
14.5 Middle East & Africa Genomics Market by Application: Forecasts 2018-2028
14.6 Middle East & Africa Genomics Market by End-User: Forecasts 2018-2028
14.7 Middle East & Africa Genomics Market Analysis, 2018 - 2028 by Country
15. Latin America Genomics Market Analysis and Forecasts 2018 - 2028
15.1 Latin America Genomics Market Outlook
15.2 Latin America Genomics Market by Technology: Forecasts 2018 – 2028
15.3 Latin America Genomics Market by Test Type: Forecasts 2018-2028
15.4 Latin America Genomics Market by Method: Forecasts 2018-2028
15.5 Latin America Genomics Market Analysis by Application: Forecasts 2018-2028
15.6 Latin America Genomics Market by End-User: Forecasts 2018-2028
15.7 Latin America Genomics Market by Country: Forecasts 2018-2028
16. Leading Companies in the Genomics Market
16.1 Illumina Inc.
16.1.1 Illumina Inc. Geographical Presence
16.1.2 Illumina Historic Roadmap
16.1.3 Illumina, Inc. Recent Developments
16.1.4 Illumina Inc, Product Portfolio
16.1.5 Illumina Inc., Sales Analysis
16.2 Agilent Technologies, Inc.
16.2.1 Agilent Technologies, Inc. Geographical Presence
16.2.2 Agilent Technologies, Inc. Recent Developments
16.2.3 Agilent Technologies, Inc. Product Portfolio
16.2.4 Agilent Technologies, Inc. Sales Analysis
16.3 Thermo Fisher Scientific, Inc.
16.3.1 Thermo Fisher Scientific, Inc. Geographical Presence
16.3.2 Thermo Fisher Scientific, Inc. Recent Developments
16.3.3 Thermo Fisher Scientific, Inc. Product Portfolio
16.3.4 Thermo Fisher Scientific, Inc. Sales Analysis
16.4 Eurofins Scientific
16.4.1 Eurofins Scientific Geographical Presence
16.4.2 Eurofins Scientific Recent Developments
16.4.3 Eurofins Scientific Product Portfolio
16.4.4 Eurofins Scientific Sales Analysis
16.5 QIAGEN NV
16.5.1 QIAGEN NV: Geographical Presence
16.5.2 QIAGEN NV Recent Developments
16.5.3 QIAGEN NV Product Portfolio
16.5.4 QIAGEN NV: Sales Analysis
16.6 GE Healthcare Life Sciences
16.6.1 GE Healthcare Life Sciences Geographical Presence
16.6.2 GE Healthcare Life Sciences Product Portfolio
16.6.3 GE Healthcare Life Sciences Sales Analysis
16.7 Eppendorf AG
16.7.1 Eppendorf AG Geographical Presence
16.7.2 Eppendorf AG Product Portfolio
16.7.3 Eppendorf AG Sales Analysis
16.8 Danaher Corporation
16.8.1 Danaher Corporation Geographical Presence
16.8.2 Danaher Corporation Product Portfolio
16.8.3 Danaher Corporation: Sales Analysis
16.9 BGI Genomics Co. Ltd.
16.9.1 BGI Genomics Co. Ltd. Geographical Presence
16.9.2 BGI Genomics Co. Ltd. Product Portfolio
16.9.3 BGI Genomics Co. Ltd. Sales Analysis
16.10 Oxford Nanopore Technologies Ltd.
16.10.1 Oxford Nanopore Technologies Ltd. Product Portfolio
16.11 F. Hoffmann-La Roche Ltd
16.11.1 F. Hoffmann-La Roche Ltd Geographical Presence
16.11.2 F. Hoffmann-La Roche Ltd Product Portfolio
16.11.3 F. Hoffmann-La Roche Ltd: Sales Analysis
16.12 SeqOne S.A.S
16.12.1 SeqOne S.A.S Product Portfolio
16.13 Other Active Companies in the Genomics Market
17. Research Interview
17.1 Interview with Jean-Marc Holder, CCO, SeqOne
17.2 Drivers of the Genomics Market
17.3 Challenges Faced by the Genomics Industry
17.4 SeqOne: Vision and Mission
17.5 French Genomics Market
17.6 Trends in the Genomics Market
17.7 SeqOne: Ambition and Strategies
18. Conclusions
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Tables
Table 2.1 Market Snapshot: Genomics Market (2017 and 2028)
Table 2.2 Genomics Market Forecast 2017 – 2028: Revenue ($bn) and AGR (%)
Table 5.1 Global Genomics Market Forecast by Technology: Revenue ($bn), AGR (%), CAGR (%), 2017 – 2028
Table 6.1 Global Genomics Market by Test Type: Revenue ($bn), AGR (%), CAGR (%), 2017 – 2028
Table 7.1 Global Genomics Market by Method: Revenue 9$bn), AGR (%), CAGR (%), 2018-2028
Table 8.1 Global Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 9.1 Global Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 10.1 Global Genomics Market by Region: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 11.1 North America Genomics Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 11.2 North America Genomics Market by Application: Revenue ($bn). AGR (%), CAGR (%), 2018-2028
Table 11.3 North America Genomics Market by Method: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 11.4 North America Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 11.5 North America Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 11.6 North America Genomics Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 12.1 Europe Genomics Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 12.2 Europe Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 12.3 Europe Genomics Market by Method: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 12.4 Europe Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 12.5 Europe Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 12.6 Europe Genomics Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 13.1 Asia-Pacific Genomics Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 13.2 Asia-Pacific Genomics Market by Test Type: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 13.3 Asia-Pacific Genomics Market by Method: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 13.4 Asia-Pacific Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 13.5 Asia-Pacific Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 13.6 Asia-Pacific Genomics Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 14.1 Middle East & Africa Genomics Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 14.2 Middle East & Africa Genomics Market by Test Type: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 14.3 Middle East & Africa Genomics Market by Method: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 14.4 Middle East & Africa Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 14.5 Middle East & Africa Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 14.6 Middle East & Africa Genomics Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 15.1 Latin America Genomics Market by Technology: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 15.2 Latin America Genomics Market by Test Type: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 15.3 Latin America Genomics Market by Method: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Table 15.4 Latin America Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 15.5 Latin America Genomics Market by End-User: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 15.6 Latin America Genomics Market by Country: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 16.1 IIlumina Inc, Product Portfolio
Table 16.2 Agilent Technolgies, Inc. Product Portfolio
Table 16.3 Agilent Technolgies, Inc. Genomics Product Portfolio
Table 16.4 Thermo Fisher Scientific, Inc. Product Portfolio
Table 16.5 Thermo Fisher Scientific, Inc. Genomics Product Portfolio
Table 16.6 Eurofins Scientific Product Portfolio
Table 16.7 Eurofins Scientific Genomics Product Portfolio
Table 16.8 QIAGEN NV: Product Portfolio
Table 16.9 GE Healthcare Life Sciences: Product Portfolio
Table 16.10 GE Healthcare Life Sciences Genomics: Product Portfolio
Table 16.11 Eppendorf AG: Product Portfolio
Table 16.12 Danaher Corporation: Product Portfolio
Table 16.13 BGI Genomics Co. Ltd.: Product Portfolio
Table 16.14 BGI Genomics Co. Ltd. Genomics: Product Portfolio
Table 16.15 Oxford Nanopore Technologies Ltd.: Product Portfolio
Table 16.16 Oxford Nanopore Technologies Ltd.: Genomics Product Portfolio
Table 16.17 F. Hoffmann-La Roche Ltd: Product Portfolio
Table 16.18 SeqOne S.A.S Product Portfolio
Table 16.19 SeqOne S.A.S Genomics Product (SeqOne Platform)
Table 16.20 Other Companies in the Genomics Industry
List of Figures
Figure 1.1 Global Genomics Market Segmentation Overview, 2017
Figure 2.1 Global Genomics Market. Segmentation Overview
Figure 2.2 Genomics Market Forecast 2017 – 2028: Revenue ($bn) and AGR (%)
Figure 3.1 Value Chain Analysis of the Genomics Market
Figure 4.1 Global Genomics Market, by Technology, 2017 (%)
Figure 4.2 Global Genomics Market by Test Type, 2017 (%)
Figure 4.3 Global Genomics Market by Method, 2017 (%)
Figure 4.4 Global Genomics Market by Application, 2017 (%)
Figure 4.5 Global Genomics Market by End-user, 2017 (%)
Figure 4.6 Global Genomics Market by Geography, 2017 (%)
Figure 5.1 Global Genomics Market by Technology: Market Share 2018 Vs 2028 (Value %)
Figure 5.2 Global Genomics Market Forecast by Technology: Revenue ($bn), 2018 – 2028
Figure 6.1 Global Genomics Market by Test Type: Market Share 2018 Vs 2028 (Value %)
Figure 6.2 Global Genomics Market by Test Type: Revenue ($bn), 2018 – 2028
Figure 7.1 Global Genomics Market by Method Market Share, 2018 Vs 2028 (Value %)
Figure 7.2 Global Genomics Market by Method: Revenue ($bn), 2018 – 2028
Figure 8.1 Global Genomics Market by Application: 2018 Vs 2028 (Value %)
Figure 8.2 Global Genomics Market by Application: Revenue ($bn), AGR (%), CAGR (%), 2018 – 2028
Figure 9.1 Global Genomics Market by End-User – 2018 Vs 2028 (Value %)
Figure 9.2 Global Genomics Market by End-User: Revenue ($bn), 2018 – 2028
Figure 10.1 Global Genomics Market Share by Geography: 2018 and 2028 (%)
Figure 10.2 Global Genomics Market by Region: 2018, (% Share)
Figure 10.3 Global Genomics Market by Region: Revenue ($bn), 2018-2028
Figure 11.1 North America Genomics Market Outlook: Revenue ($bn), 2018, 2021, 2024, 2028
Figure 11.2 Market Attractiveness Analysis by Technology: Market Share (%), CAGR (%)
Figure 11.3 Market Attractiveness Analysis by Test Type: Market Share (%), CAGR (%)
Figure 11.4 Market Attractiveness Analysis by Method: Market Share (%), CAGR (%)
Figure 11.5 Market Attractiveness Analysis by Application: Market Share (%), CAGR (%)
Figure 11.6 Market Attractiveness Analysis by End-User: Market Share (%), CAGR (%)
Figure 11.7 Market Attractiveness Analysis by Country: Market Share (%), CAGR (%)
Figure 11.8 North America Genomics Market by Technology: Revenue ($bn)
Figure 11.9 North America Genomics Market by Test Type: Revenue ($bn), 2018-2028
Figure 11.10 North America Genomics Market by Method: Revenue ($bn), 2018-2028
Figure 11.11 North America Genomics Market by Application: Forecasts 2018-2028
Figure 11.12 North America Genomics Market by End-user: Revenue ($bn), 2018-2028
Figure 11.13 North America Genomics Market by Country: Revenue ($bn), 2018-2028
Figure 12.1 Europe Genomics Market Outlook: Revenue ($bn), 2018. 2021, 2024, 2028
Figure 12.2 Market Attractiveness Analysis by Technology: Market Share (%), CAGR (%)
Figure 12.3 Market Attractiveness Analysis by Test Type: Market Share (%), CAGR (%)
Figure 12.4 Market Attractiveness Analysis by Method: Market Share (%), CAGR (%)
Figure 12.5 Market Attractiveness Analysis by Application: Market Share (%), CAGR (%)
Figure 12.6 Market Attractiveness Analysis by End-User: Market Share (%), CAGR (%)
Figure 12.7 Market Attractiveness Analysis by Country: Market Share (%), CAGR (%)
Figure 12.8 Europe Genomics Market by Technology: Revenue ($bn), 2018-2028
Figure 12.9 Europe Genomics Market by Test Type: Revenue ($bn), 2018-2028
Figure 12.10 Europe Genomics Market by Method: Revenue ($bn), 2018-2028
Figure 12.11 Europe Genomics Market by Application: Revenue ($bn), 2018-2028
Figure 12.12 Europe Genomics Market by End-user: Revenue ($bn), 2018-2028
Figure 12.13 Europe Genomics Market by Country: Revenue ($bn), 2018-2028
Figure 13.1 Asia-Pacific Genomics Market Outlook: Revenue ($bn), 2018, 2021, 2024, 2028
Figure 13.2 Market Attractiveness Analysis by Technology: Market Share (%), CAGR (%)
Figure 13.3 Market Attractiveness Analysis by Test Type: Market Share (%), CAGR (%)
Figure 13.4 Market Attractiveness Analysis by Method: Market Share (%), CAGR (%)
Figure 13.5 Market Attractiveness Analysis by Application: Market Share (%), CAGR (%)
Figure 13.6 Market Attractiveness Analysis by End-User: Market Share (%), CAGR (%)
Figure 13.7 Market Attractiveness Analysis by Country: Market Share (%), CAGR (%)
Figure 13.8 Asia-Pacific Genomics Market by Technology: Revenue ($bn), 2018-2028
Figure 13.9 Asia-Pacific Genomics Market by Test Type: Revenue ($bn), 2018-2028
Figure 13.10 Asia-Pacific Genomics Market by Method: Revenue ($bn), 2018-2028
Figure 13.11 Asia-Pacific Genomics Market by Application: Revenue ($bn), 2018-2028
Figure 13.12 Asia-Pacific Genomics Market by End-User: Revenue ($bn), 2018-2028
Figure 13.13 Asia-Pacific Genomics Market by Country: Revenue ($bn), 2018-2028
Figure 14.1 Middle East & AfricaGenomics Market Outlook: Revenue ($bn), 2018, 2021, 2024, 2028
Figure 14.2 Market Attractiveness Analysis by Technology: Market Share (%), CAGR (%)
Figure 14.3 Market Attractiveness Analysis by Test Type: Market Share (%), CAGR (%)
Figure 14.4 Market Attractiveness Analysis by Method: Market Share (%), CAGR (%)
Figure 14.5 Market Attractiveness Analysis by Application: Market Share (%), CAGR (%)
Figure 14.6 Market Attractiveness Analysis by End-User: Market Share (%), CAGR (%)
Figure 14.7 Market Attractiveness Analysis by Country: Market Share (%), CAGR (%)
Figure 14.8 Genomics Market by Technology: Revenue ($bn), 2018-2028
Figure 14.9 Middle East & Africa Genomics Market by Test Type: Revenue ($bn), 2018-2028
Figure 14.10 Middle East & Africa Genomics Market by Method: Revenue ($bn), 2018-2028
Figure 14.11 Middle East & Africa Genomics Market by Application: Revenue ($bn), 2018-2028
Figure 14.12 Middle East & Africa Genomics Market by End-User: Revenue ($bn), 2018-2028
Figure 14.13 Middle East & Africa Genomics Market by Country: Revenue ($bn), 2018-2028
Figure 15.1 Latin America Genomics Market Outlook: Revenue ($bn), 2018, 2021, 2024, 2028
Figure 15.2 Market Attractiveness Analysis by Technology: Market Share (%), CAGR (%)
Figure 15.3 Market Attractiveness Analysis by Test Type: Market Share (%), CAGR (%)
Figure 15.4 Market Attractiveness Analysis by Method: Market Share (%), CAGR (%)
Figure 15.5 Market Attractiveness Analysis by Application: Market Share (%), CAGR (%)
Figure 15.6 Market Attractiveness Analysis by End-User: Market Share (%), CAGR (%)
Figure 15.7 Market Attractiveness Analysis by Country: Market Share (%), CAGR (%)
Figure 15.8 Latin America Genomics Market by Technology: Revenue ($bn), 2018-2028
Figure 15.9 Latin America Genomics Market by Test Type: Revenue ($bn), 2018-2028
Figure 15.10 Latin America Genomics Market by Method: Revenue ($bn), 2018-2028
Figure 15.11 Latin America Genomics Market by Application: Revenue ($bn), 2018-2028
Figure 15.12 Latin America Genomics Market. Analysis by End-User: Revenue ($bn), 2018-2028
Figure 15.13 Latin America Genomics Market. Analysis, 2018 - 2028 by Country
Figure 16.1 Leading Companies, Genomics Market Share, 2017 (% share)
Figure 16.2 Illumina Inc: Sales Analysis by Business Segments ($m) 2015 - 2017
Figure 16.3 Illumina Inc.: Sales Analysis by Business Segments (% Share), 2017
Figure 16.4 Illumina Inc.: Sales Analysis by Geographic Segments ($m), 2015 - 2017
Figure 16.5 Agilent Technologies, Inc: Sales Analysis ($m), 2015 - 2017
Figure 16.6 Agilent Technologies, Inc.: Sales Analysis by Business Segments (% Share), 2017
Figure 16.7 Agilent Technologies: Inc. Sales Analysis by Product Segments (% Share), 2017
Figure 16.8 Agilent Technologies, Inc.: Sales Analysis by Product Segments ($m), 2015 - 2017
Figure 16.9 Agilent Techologies, Inc.: Sales Analysis by Geography (% Share), 2017
Figure 16.10 Thermo Fisher Scientific, Inc.: Sales Analysis ($m), 2015 - 2017
Figure 16.11 Thermo Fisher Scientific, Inc.: Sales Analysis by Business Segments (% Share), 2017
Figure 16.12 Thermo Fisher Scientific, Inc.: Sales Analysis by Product Segments (% Share), 2017
Figure 16.13 Thermo Fisher Scientific, Inc.: Sales Analysis by Product Segments ($m), 2015 - 2017
Figure 16.14 Thermo Fisher Scientific, Inc.: Sales Analysis by Geography (% Share), 2017
Figure 16.15 Eurofins Scientific Sales Analysis (€m), 2015 - 2017
Figure 16.16 Eurofins Scientific Sales Analysis by Geography (% Share), 2017
Figure 16.17 Eurofins Scientific: Sales Analysis by Geography (€m), 2015-2017
Figure 16.18 QIAGEN NV: Sales Analysis ($m), 2015 - 2017
Figure 16.19 QIAGEN NV: Sales Analysis by Business Segments (% Share), 2017
Figure 16.20 QIAGEN NV: Sales Analysis by Geography ($m), 2015 - 2017
Figure 16.21 QIAGEN NV: Sales Analysis by Geography (% Share), 2017
Figure 16.22 GE Healthcare Life Sciences: Sales Analysis ($m), 2015 - 2017
Figure 16.23 GE Healthcare Life Sciences: Sales Analysis by Business Segments (% Share), 2017
Figure 16.24 GE Healthcare Life Sciences: Sales Analysis by Product Segments (% Share), 2017
Figure 16.25 GE Healthcare Life Sciences: Sales Analysis by Geography (% Share), 2017
Figure 16.26 GE Healthcare Life Sciences: Sales Analysis by Geography ($m), 2015 - 2017
Figure 16.27 Eppendorf AG: Sales Analysis (€m), 2015 - 2017
Figure 16.28 Eppendorf AG: Sales Analysis by Geography (% Share), 2017
Figure 16.29 Eppendorf AG: Sales Analysis by Geography (€m), 2015 - 2017
Figure 16.30 Danaher Corporation: Sales Analysis ($m), 2015 - 2017
Figure 16.31 Danaher Corporation: Sales Analysis by Business Segments (% Share), 2017
Figure 16.32 Danaher Corporation: Sales Analysis by Product Segments ($m), 2015 - 2017
Figure 16.33 Danaher Corporation Sales Analysis by Geography (%Share), 2017
Figure 16.34 BGI Genomics Co. Ltd.: Sales Analysis (Mn CNY), 2015 - 2017
Figure 16.35 BGI Genomics Co. Ltd.: Sales Analysis by Business Segments (% Share), 2017
Figure 16.36 BGI Genomics Co. Ltd.: Sales Analysis by Product Segments (Mn CNY), 2015 - 2017
Figure 16.37 BGI Genomics Co. Ltd.: Sales Analysis by Geography (% Share), 2017
Figure 16.38 BGI Genomics Co. Ltd.: Sales Analysis by Geography (Mn CNY), 2015 - 2017
Figure 16.39 F. Hoffmann-La Roche Ltd: Sales Analysis (CHF Mn), 2015 - 2017
Figure 16.40 F. Hoffmann-La Roche Ltd: Sales Analysis by Business Segments (% Share), 2017
Figure 16.41 F. Hoffmann-La Roche Ltd: Sales Analysis by Product Segments (CHF Mn), 2015 - 2017
Figure 16.42 F. Hoffmann-La Roche Ltd: Sales Analysis by Geography (% Share), 2017
Figure 16.43 F. Hoffmann-La Roche Ltd: Sales Analysis by Geography (CHF Mn), 2015 - 2017
10x Genomics
23andMe, Inc.
Affymetrix
Agilent Technologies, Inc.
Ancestry
Annoroad
BGI
Bio-Rad Laboratories
Bristol-Myers Squibb
CENTOGENE AG
Clinical Genomics Technologies Pty Ltd.
Color Genomics
Core Informatics
Counsyl
CRISPR Therapeutics
Cura Integrative Medicine
Danaher
DeCODE
Deep Genomics
Edico Genome
Editas Medicine
Epicentre Biotechnologies
Eppendorf
Eurofins Scientific
F. Hoffmann-La Roche
Foundation Medicine, Inc.
Futura Genetics
GATC Biotech
GE Healthcare
Gene by Gene Ltd
Genohm
GenomeDx Biosciences, Inc.
Genomic Health, Inc.
Genomics England
Genomix Nutrition, Inc.
IBM Watson for Genomics
Illumina
Inivata
Intellia Therapeutics
Invitae Corporation
Iverson Genetic Diagnostics, Inc.
Life Technologies
Loxo Oncology
MedGenome
Metagenics, Inc
MyDNA
Myriad Genetics, Inc.
Natera, Inc.
National Geographic’s ancestry test
NeoGenomics, Inc.
NutraGene
Nutrigenomix
OPKO Health, Inc.
Oxford Nanopore Technologies Ltd.
PacBio
Pacific Biosciences of California
Pathgroup
PerkinElmer, Inc.
Personalis, Inc.
PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH
Qiagen
Quest Diagnostics Incorporated
Retrogen, Inc.
Roche
Rosetta Genomics, Ltd.
Sentieon
Solexa, Inc.
Strand Life Sciences Pvt. Ltd.
Thermo Fisher Scientific
Verge Genomics
Verily Life Sciences
Veritas Genetics
WellGen Inc.
WuXi NextCODE
XCODE Life Sciences Pvt. Ltd.
List of Organizations Mentioned in the Report
Emory Genetics Laboratory (EGL)
Emory University's School of Medicine
National Institutes of Health (NIH)
Organization for Economic Cooperation and Development (OECD)
South African Medical Research Council (SAMRC)
The Brazilian Society of Medical Genetics [Sociedade Brasileira de Genética Médica (SBGM)
University of Leuven
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
